Dynamic genomic changes in methotrexate-resistant human cancer cell lines beyond DHFR amplification suggest potential new targets for preventing drug resistance.
Meng XN, Ma JF, Liu YH, Li SQ, Wang X, Zhu J, Cai MD, Zhang HS, Song T, Xing S, Hou LQ, Guo H, Cui XB, Han J, Liu P, Ji GH, Sun WJ, Yu JC, Fu SB.
Meng XN, et al. Among authors: zhang hs.
Br J Cancer. 2024 Apr 9. doi: 10.1038/s41416-024-02664-0. Online ahead of print.
Br J Cancer. 2024.
PMID: 38594370